Achmea Investment Management B.V. Eli Lilly & CO Transaction History

Achmea Investment Management B.V.

$6.06 Billion
Q3 2024

A detailed history of Achmea Investment Management B.V. transactions in Eli Lilly & CO stock. As of the latest transaction made, Achmea Investment Management B.V. holds 59,846 shares of LLY stock, worth $46.6 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

59,846

Previous 60,735 1.46%

Holding current value

$46.6 Million

Previous $55 Million 3.58%

% of portfolio

0.87%

Previous 0.98%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $686,432 - $853,457	-889 Reduced 1.46%	59,846 $53 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $263,852 - $330,890	364 Added 0.6%	60,735 $55 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $6.89 Million - $9.21 Million	-11,627 Reduced 16.15%	60,371 $47 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $2.92 Million - $3.44 Million	-5,551 Reduced 7.16%	71,998 $42 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $360,801 - $497,418	830 Added 1.08%	77,549 $41.7 Million
Q2 2023 Jul 24, 2023	BUY	$350.74 - $468.98 $5.44 Million - $7.27 Million	15,505 Added 25.33%	76,719 $36 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $2.08 Million - $2.44 Million	6,685 Added 12.26%	61,214 $21 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $672,361 - $783,434	-2,091 Reduced 3.69%	54,529 $18.7 Million
Q3 2022 Oct 27, 2022	SELL	$296.48 - $337.87 $3.66 Million - $4.17 Million	-12,334 Reduced 17.89%	56,620 $18.3 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $48,777 - $57,272	175 Added 0.25%	68,954 $22.4 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $2.11 Million - $2.62 Million	-8,996 Reduced 11.57%	68,779 $19.7 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $1.11 Million - $1.38 Million	-4,938 Reduced 5.97%	77,775 $21.5 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1.33 Million - $1.64 Million	-5,997 Reduced 6.76%	82,713 $19.1 Million
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $477,013 - $617,012	2,642 Added 3.07%	88,710 $20.4 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $362,489 - $469,260	-2,206 Reduced 2.5%	86,068 $16.1 Million
Q4 2020 Feb 22, 2021	BUY	$130.46 - $172.63 $2.1 Million - $2.77 Million	16,070 Added 22.26%	88,274 $14.9 Million
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $10.6 Million - $12.2 Million	72,204 New	72,204 $10.7 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $10.7 Million - $13.3 Million	-89,946 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $623,450 - $772,199	-5,831 Reduced 6.09%	89,946 $11.8 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $8.38 Million - $9.11 Million	-78,465 Reduced 45.03%	95,777 $10.7 Million
Q2 2019 Aug 06, 2019	BUY	$110.79 - $129.32 $965,978 - $1.13 Million	8,719 Added 5.27%	174,242 $19.3 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $2 Million - $2.36 Million	-17,994 Reduced 9.81%	165,523 $21.5 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $8.04 Million - $9.01 Million	75,939 Added 70.59%	183,517 $21.2 Million
Q3 2018 Nov 06, 2018	BUY	$85.86 - $107.31 $948,753 - $1.19 Million	11,050 Added 11.45%	107,578 $11.5 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $1.78 Million - $2.1 Million	-23,941 Reduced 19.87%	96,528 $7.47 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $5.5 Million - $5.9 Million	67,178 Added 126.06%	120,469 $10.2 Million
Q3 2017 Nov 09, 2017	SELL	$77.07 - $85.54 $122,772 - $136,265	-1,593 Reduced 2.9%	53,291 $4.56 Million
Q2 2017 Aug 29, 2017	BUY	N/A	54,884	54,884 $4.52 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account

Achmea Investment Management B.V. Eli Lilly & CO Transaction History